Discover Excellence

Uristatв Prestige Consumer Healthcare Inc

uristatв prestige consumer healthcare inc
uristatв prestige consumer healthcare inc

Uristatв Prestige Consumer Healthcare Inc Your trusted partner in urinary health. uristat® contains the #1 doctor recommended otc ingredient for fast, temporary relief of symptoms associated with urinary tract infections. ©2024 prestige consumer healthcare inc. Primary ir contact. irinquiries@prestigebrands prestige consumer healthcare inc. 660 white plains road – ste 250 tarrytown, ny 10591 telephone: 914 524 6819. transfer agent. the investor relations website contains information about prestige consumer healthcare inc.'s business for stockholders, potential investors, and financial analysts.

uristatв prestige consumer healthcare inc
uristatв prestige consumer healthcare inc

Uristatв Prestige Consumer Healthcare Inc Primary ir contact. irinquiries@prestigebrands prestige consumer healthcare inc. 660 white plains road – ste 250 tarrytown, ny 10591 telephone: 914 524 6819. Yeast infection treatment & vaginal care products. treat your yeast infection from the comfort of your home with monistat, the #1 gynecologist recommended brand*. *vaginal antifungal category; iqvia survey of 2,695 gynecologists, dec 2018 through nov 2019. Tarrytown, n.y., may 04, 2023 (globe newswire) prestige consumer healthcare inc. (nyse:pbh) today reported financial results for its fourth quarter and fiscal year ended march 31, 2023. “we are pleased to exceed our fourth quarter and full year fiscal 2023 guidance, which included organic growth above our long term outlook and continued. Prestige consumer healthcare inc. north american otc healthcare. revenue of $279.3 million in q1, up 0.8% versus prior year and up 1.8% excluding foreign currencyreduced leverage ratio to 3.2x at.

uristatв prestige consumer healthcare inc
uristatв prestige consumer healthcare inc

Uristatв Prestige Consumer Healthcare Inc Tarrytown, n.y., may 04, 2023 (globe newswire) prestige consumer healthcare inc. (nyse:pbh) today reported financial results for its fourth quarter and fiscal year ended march 31, 2023. “we are pleased to exceed our fourth quarter and full year fiscal 2023 guidance, which included organic growth above our long term outlook and continued. Prestige consumer healthcare inc. north american otc healthcare. revenue of $279.3 million in q1, up 0.8% versus prior year and up 1.8% excluding foreign currencyreduced leverage ratio to 3.2x at. Website. prestigebrands . prestige consumer healthcare inc. (formerly prestige brands, inc.) is an american company that markets and distributes over the counter healthcare and household cleaning products. it was formed by the merger of medtech products, inc., prestige brands international, and the spic and span company in 1996. Tarrytown, n.y., july 02, 2024 (globe newswire) prestige consumer healthcare inc. (nyse:pbh) today announced that it will issue its fiscal 2025 first quarter earnings release on thursday.

uristatв prestige consumer healthcare inc
uristatв prestige consumer healthcare inc

Uristatв Prestige Consumer Healthcare Inc Website. prestigebrands . prestige consumer healthcare inc. (formerly prestige brands, inc.) is an american company that markets and distributes over the counter healthcare and household cleaning products. it was formed by the merger of medtech products, inc., prestige brands international, and the spic and span company in 1996. Tarrytown, n.y., july 02, 2024 (globe newswire) prestige consumer healthcare inc. (nyse:pbh) today announced that it will issue its fiscal 2025 first quarter earnings release on thursday.

Comments are closed.